1010Genome
1010Genome is a Singapore-based bioinformatics and sequencing services provider founded in the early 2020s.
Profile
Provides DNA/RNA sequencing and analysis services for research and biotechnology applications.
1010Genome is a Singapore-based bioinformatics and sequencing services provider founded in the early 2020s. The company specializes in next-generation sequencing (NGS) data analysis, offering services across platforms like Illumina, PacBio, Oxford Nanopore, Element Biosciences, and Parse Biosciences. Their product portfolio includes whole genome sequencing, exome sequencing, RNA-Seq, metagenomics, and custom bioinformatics solutions.
With a headcount of 1-10 employees as of 2026, 1010Genome operates as a lean but focused player in the genomics services market, catering primarily to academic and biotech research clients. The company's technical capabilities span genome assembly, structural variant detection, and pathway analysis, with case studies demonstrating projects in microbial genomics and eukaryotic genome annotation. While financials remain undisclosed, their Crunchbase profile indicates active operations with a growth score suggesting steady but unspectacular traction.
What stands out in 2026 is their embrace of emerging sequencing technologies like single-cell RNA-Seq and nanopore sequencing, positioning them as a flexible alternative to larger genomic service providers. Their on-demand computing infrastructure offering also reflects an adaptive approach to bioinformatics workloads.
Who buys this
- Academic research laboratories
- Biotechnology startups
- Pharmaceutical R&D teams
- Agricultural genomics researchers
- Clinical research organizations
Strengths and what to watch
Strengths
- Multi-platform sequencing expertise (Illumina, PacBio, Nanopore)
- Specialized bioinformatics pipelines for niche applications like structural variant detection
- On-demand cloud computing infrastructure for scalable analysis
Watch for
- Limited public funding history or growth metrics
- Small team size may constrain service capacity
- Intense competition from well-funded sequencing service providers
Key Information
- Founded
- 2015
- Headquarters
- Singapore
Frequently Asked Questions
What does 1010Genome do?
1010Genome provides DNA/RNA sequencing and bioinformatics analysis services for research and biotech applications. The Singapore-based company specializes in next-generation sequencing across platforms like Illumina and Nanopore, offering genome assembly, variant detection, and RNA-Seq analysis primarily to academic and biotech clients.
Which sequencing technologies does 1010Genome support?
1010Genome works with Illumina, PacBio, Oxford Nanopore, Element Biosciences, and Parse Biosciences platforms. Their technical capabilities include whole genome sequencing, exome sequencing, and emerging methods like single-cell RNA-Seq, positioning them as a multi-platform service provider.
Who uses 1010Genome's services?
Primary customers include academic research labs, biotech startups, pharmaceutical R&D teams, agricultural genomics researchers, and clinical research organizations. The company focuses on research clients needing specialized sequencing and analysis rather than clinical diagnostics.
What makes 1010Genome different from other sequencing providers?
1010Genome combines multi-platform sequencing expertise with niche bioinformatics capabilities like structural variant detection. Their cloud-based infrastructure and focus on emerging technologies like nanopore sequencing offer flexibility smaller than large providers. However, their small team size limits service capacity.
Does 1010Genome offer single-cell RNA sequencing?
Yes, 1010Genome has adopted single-cell RNA-Seq as part of their 2026 service portfolio. This positions them alongside larger providers in offering cutting-edge transcriptomics analysis, though their small team size may affect throughput capacity compared to industry leaders.
Where is 1010Genome located?
1010Genome operates from Singapore, serving global research clients. The company's Southeast Asian base provides regional access to sequencing services, though their 1-10 person team size as of 2026 suggests primarily serving niche academic and biotech markets rather than large-scale commercial projects.
Sources
- www.crunchbase.com — Company overview, location, and headcount
- www.1010genome.com — Service offerings and technical capabilities
- www.linkedin.com — Company presence and service focus
- 1010genome.com — Detailed sequencing platform offerings